Difficulty: Medium
Average Score: 73%
Practice
Which of the following is approved for the treatment of hemorrhagic stroke?
Correct answer
C
Rationale
In the context of treating hemorrhagic stroke, the correct answer is C) Nimodipine. Nimodipine is a calcium channel blocker that is specifically approved for the treatment of subarachnoid hemorrhage, a type of hemorrhagic stroke. It is the only medication among the options indicated for this condition.
Option A) Amyl nitrite is used for acute relief of angina pectoris but is not indicated for hemorrhagic stroke. Option B) Hydralazine is a vasodilator primarily used in hypertension and heart failure, not for hemorrhagic stroke. Option D) Nifedipine is another calcium channel blocker, but it is not approved for treating hemorrhagic stroke specifically.
Educationally, understanding the specific indications of medications is crucial in clinical practice. In the case of hemorrhagic stroke, using a medication like Nimodipine can improve patient outcomes by targeting the underlying pathophysiology. This question highlights the importance of knowing the approved uses of drugs to provide effective and evidence-based care.
Option A) Amyl nitrite is used for acute relief of angina pectoris but is not indicated for hemorrhagic stroke. Option B) Hydralazine is a vasodilator primarily used in hypertension and heart failure, not for hemorrhagic stroke. Option D) Nifedipine is another calcium channel blocker, but it is not approved for treating hemorrhagic stroke specifically.
Educationally, understanding the specific indications of medications is crucial in clinical practice. In the case of hemorrhagic stroke, using a medication like Nimodipine can improve patient outcomes by targeting the underlying pathophysiology. This question highlights the importance of knowing the approved uses of drugs to provide effective and evidence-based care.